Platform Applications
Structured stability enabling deployment across defined commercial domains.
The Amino Five stabilisation process supports deployment of instability sensitive bioactive compounds across multiple commercial sectors. Applications extend beyond formulation control to enable structured scale, distribution confidence and product innovation within defined market environments.
The platform architecture is designed to support controlled expansion across human performance, longevity, clinical and emerging bioactive applications.
Core Application Domains
Deployment across defined commercial sectors.
Flagship Deployment: Liquid Stable Creatine
Demonstrated stability within ready to drink systems.
Liquid Stable Creatine represents a leading commercial deployment of the Amino Five stabilisation architecture.
By embedding process control at formulation stage, creatine can be deployed within structured liquid systems while maintaining defined molecular integrity across targeted shelf life parameters.
This deployment demonstrates scalability, distribution confidence and manufacturing compatibility within modern beverage environments.
The creatine application validates platform capability while preserving architectural flexibility for additional compound classes.
Expandable Platform
Stability architecture designed for continued compound expansion.
The Amino Five stabilisation process is designed to extend beyond current deployments.
The underlying process architecture supports additional instability sensitive bioactive compounds subject to defined technical, regulatory and commercial criteria.
As new compound classes emerge and market demand evolves, the platform is structured to evaluate and integrate expansion pathways while preserving process integrity and enterprise value.
Current applications validate capability. They do not define scope.
For structured participation pathways, refer to Strategic Engagement.